Assays for hepatitis B surface antigen (HBsAg) are the most frequently ... testing and also to ascertain likely cause of weakly positive (grayzone) results. Results During the 17 month study ...

Spontaneous loss of hepatitis B e antigen (HBeAg) followed by seroconversion ... regimen and timing of therapy for a patient with HBeAg-positive hepatitis. Accreditation: Tufts University School ...

The trial was tailored to evaluate the therapy at multiple ascending dose levels, with three dose administrations per level.

Study: AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus ... system in people who are either positive for the HBV surface antigen (HBsAg) or HBV core antibody ...

The report highlighted that testing was conducted for the presence of Hepatitis B surface antigen (HBsAg ... in the number of individuals testing positive for Hepatitis B since 2022.

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...

A functional cure is said to have been achieved if a biomarker called hepatitis B surface antigen (HBsAg) is cleared from the blood and remains undetectable after stopping all treatment.

Hepatitis B surface antigen vaccine (recombinant ... of hepatitis B virus to infants born to mothers who are HBsAg positive if vaccination is delayed. Infants Weighing Less Than 2000 g Delay ...

For patients at high risk of hepatitis B reactivation ... antibodies to HBV surface Ag (anti-HBs), and HBV total core Ag (anti-HBc). Those with positive anti-HBc are at risk for HBVr.

bepirovirsen at a dose of 300 mg per week over 24 weeks resulted in sustained hepatitis B surface antigen (HBsAg) and HBV DNA loss to below the limits of detection in 9% to 10% of participants ...